Impairment of pulmonary bacterial defense mechanisms by immunosuppressive agents.
D000336:Aerosols; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000494:pharmacology; D001379:Azathioprine / Q000008:administration & dosage / Q000494:pharmacology; D001419:Bacteria / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007239:Infections / Q000276:immunology; D008171:Lung Diseases / Q000209:etiology; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology; D051379:Mice; D008854:Microscopy, Electron; D010587:Phagocytosis / Q000187:drug effects; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000276:immunology; D011817:Rabbits; D013203:Staphylococcal Infections
D000336:Aerosols; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D001379:Azathioprine; D008775:Methylprednisolone